Our previous studies have shown that ATO significantly increases the level of Nrf2 in a human lung carcinoma cell line, A549 cell line14, suggesting that upregulation of Nrf2 is involved in resistance of A549 cells to ATO. The gene discussed is NFE2L2; the disease is lung carcinoma.